Evidence map›Paper›PMID 32101568›Full record

ArticlePloS one2020

KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation.

Kazuhiro Nishimura, Moemi Okamoto, Rina Shibue, Toshio Mizuta, Toru Shibayama, Tetsuhiko Yoshino, Teruki Murakami, Masashi Yamaguchi, Satoshi Tanaka, Toshihiko Toida and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Anti-Allergic Effects ofAntioxidants (Basel, Switzerland) · 2021
    Article
  3. Review
  4. Translational Regulation of Clock Genes BMAL1 and REV-ERBα by Polyamines.International journal of molecular sciences · 2021
    Article
  5. Histamine and histidine decarboxylase: Immunomodulatory functions and regulatory mechanisms.Genes to cells : devoted to molecular & cellular mechanisms · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kazuhiro NishimuraGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.ORCID 0000-0002-6209-5522
Moemi OkamotoGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Rina ShibueGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Toshio MizutaGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Toru ShibayamaGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Tetsuhiko YoshinoGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Teruki MurakamiGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Masashi YamaguchiMedical Mycology Research Center, Chiba University, Chiba, Japan.
Satoshi TanakaDepartment of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan.
Toshihiko ToidaGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Kazuei IgarashiGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Chiba University · JPChiba University Hospital · JPKyoto Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells have secretory granules containing chemical mediators such as histamine and play important roles in the immune system. Polyamines are essential factors for cellular processes such as gene expression and translation. It has been reported that secretory granules contain both histamine and polyamines, which have similar chemical structures and are produced from the metabolism of cationic amino acids. We investigated the effect of polyamine depletion on mast cells using bone marrow-derived mast cells (BMMCs). Polyamine depletion was induced using α-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase. DFMO treatment resulted in a significant reduction of cell number and abnormal secretory granules in BMMCs. Moreover, the cells showed a 2.3-fold increase in intracellular histamine and up-regulation of histidine decarboxylase (HDC) at the transcriptional level during BMMC differentiation. Levels of the transcription factor kruppel-like factor 4 (KLF4) greatly decreased upon DFMO treatment; however, Klf4 mRNA was expressed at levels similar to controls. We determined the translational regulation of KLF4 using reporter genes encoding Klf4-luc2 fusion mRNA, for transfecting NIH3T3 cells, and performed in vitro translation. We found that the efficiency of KLF4 synthesis in response to DFMO treatment was enhanced by the existence of a GC-rich 5'-untranslated region (5'-UTR) on Klf4 mRNA, regardless of the recognition of the initiation codon. Taken together, these results indicate that the enhancement of histamine synthesis by DFMO depends on the up-regulation of Hdc expression, achieved by removal of transcriptional suppression of KLF4, during differentiation.

Indexed as

AnimalsBone MarrowBone Marrow CellsCell DifferentiationEflornithineFemaleHistamineHistidine DecarboxylaseKruppel-Like Factor 4Kruppel-Like Transcription FactorsMast CellsMiceMice, Inbred C57BLNIH 3T3 CellsOrnithine DecarboxylasePolyaminesEflornithineHistamineHistidine DecarboxylaseKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsOrnithine DecarboxylasePolyaminesSpermidine

Identifiers

PMID32101568
PMCPMC7043748
OpenAlexW3008787032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.